Company Overview of Enumeral Biomedical Holdings, Inc.
Key Executives for Enumeral Biomedical Holdings, Inc.
|Wael Fayad||7 Relationships||Chairman, Chief Executive Officer and President||--|
|Kevin G. Sarney CPA||No Relationships||Chief Accounting Officer, Vice President of Finance and Treasurer||51|
|Matthew A. Ebert||No Relationships||General Counsel and Secretary||--|
Enumeral Biomedical Holdings, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Wael Fayad||7 Relationships||Enumeral Biomedical Holdings, Inc.||--|
|Barry C. Buckland Ph.D.||51 Relationships||Enumeral Biomedical Holdings, Inc.||68|
|Paul J. Sekhri||198 Relationships||Lycera Corp.||58|
|Robert J. Easton||29 Relationships||Craig Drill Capital Corporation||71|
|Robert L. Van Nostrand BS||40 Relationships||Metabolix, Inc.||59|
Enumeral Biomedical Holdings, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||Robert J. Easton||29 Relationships||3 Executives|
|Compensation Committee||Paul J. Sekhri||198 Relationships||3 Executives|
|Nominating Committee Ph.D.||Barry C. Buckland||51 Relationships||3 Executives|
|Corporate Governance Committee Ph.D.||Barry C. Buckland||51 Relationships||3 Executives|
|Advisory Board Ph.D.||Barry C. Buckland||51 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.